CETP TaqIB polymorphism, serum lipid levels and risk of atrial fibrillation: A case-control study

Journal of Atrial Fibrillation

Volumn 6, Issue 6, 2014, Pages 24-29

  Galati, Francesca ^a   Colonna, Paolo ^b   Galati, Antonio ^c   Ciardiello, Carmine ^d   Bozzetti, Maria P ^a   Massari, Serafina ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b Clinic for Infectious Diseases   (Italy)

^c Card G Panico Hospital   (Italy)

^d Boston Scientific Italia ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84901636480     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barter PJ, Kastelein JJ. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J Am Coll Cardiol. 2006; 47: 492-499. (Pubitemid 43170835)
2. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem. 1995; 64: 235-257.
3. Bruce C, Chouinard Jr RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 1998; 18: 297-330. (Pubitemid 28366870)
4. Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res. 1987; 15: 46-98.
5. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin. Genet. 1989; 35: 49-56. (Pubitemid 19029791)
6. Corbex M, Poirier O, Fumeron F, Betoulle D, Evans A, Ruidavets JB, Arveiler d, Luc G, Tiret L, Cambien F. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol. 2000; 19: 64-80. (Pubitemid 30445638)
7. Dachet C, Poirier O, Cambien F, Chapman J, Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/ Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol. 2000; 20: 507-515. (Pubitemid 30086110)
8. Dullaart RP, Sluiter WJ. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics. 2008; 9: 747-63.
9. Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart RP, Keavney B, Ye Z, Danesh J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008; 299: 2777-2788. (Pubitemid 351846853)
10. Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, Verna R. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet. 2001; 60: 374-380. (Pubitemid 33094904)
11. Asselbergs FW, Moore JH, Van Den Berg MP, Rimm EB, de Boer RA, Dullaart RP, Navis G, van Gilst WH. A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study. BMC Medical Genetics. 2006; 7: 39-48.
12. Sinner MF, Lubitz SA, Pfeufer A, Makino S, Beckmann BM, Lunetta KL, Steinbeck G, Perz S, Rahman R, Sonni A, Greenberg SM, Furie KL et al. Lack of Replication in Polymorphisms Reported to be Associated with Atrial Fibrillation. Heart Rhythm. 2011; 8: 403-409.
13. Fatini C, Sticchi E, Genuardi M, Sofi F, Gensini F, Gori AM, Lenti M, Michelucci A, Abbate R, Gensini GF. Analysis of minK and eNOS genes as candidate loci for predisposition to nonvalvular atrial fibrillation. Eur Heart J. 2006; 27: 1712-1718. (Pubitemid 44026432)
14. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ, Hsu KL, Tseng CD, Lien WP, Tseng YZ, Huang SK. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J. 2002; 144: 485-490.
15. Schreieck J, Dostal S, von Beckerath N, Wacker A, Flory M, Weyerbrock S, Koch W, Schomig A, Schmitt C. C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J. 2004; 148: 545-550. (Pubitemid 39265132)
16. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation. 2004; 109: 1640-1646. (Pubitemid 38451721)
17. Wolfe ML, Rader DJ. Cholesteryl ester transfer protein and coronary artery disease: an observation with therapeutic implications. Circulation. 2004; 110: 1338-1340. (Pubitemid 39238009)
18. Rejeb J, Omezzine A, Rebhi L, Naffeti I, Kchok K, Belkahla R et al. Association of the cholesteryl ester transfer protein TaqIB2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population. Arch Cardiovasc Dis. 2008; 101: 629-636.
19. Brousseau M, O'Connor JJ, Ordovas JM, Collins D, Otvos JD, Massov T et al. Cholesteryl ester transfer protein TaqIB2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease and points in men with HDL deficiency. Arterioscler Thromb Vasc Biol. 2002; 22: 1148-1154. (Pubitemid 34764866)
20. Boekholdt SM, Sacks FM, Jukema IW, Shepherd J, Freeman DJ, McMahon AD et al. Cholesteryl ester transfer protein TaqIB variant, high density lipoprotein cholesterol levels, cardiovascular risk and efficacy of pravastatin treatment. Individual patient meta-analysis of 13677 subjects. Circulation. 2005; 111: 278-287. (Pubitemid 40165333)
21. Heeringa J, van der Kulp DAM, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GYH, Witteman JCM. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-953.
22. Korantzopoulos P, Kolettis T, Siogas K, Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit. 2003; 9: RA225-229. (Pubitemid 37303894)
23. Cuchel M, Wolfe ML, deLemos AS, Rader DJ. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis. 2002; 163: 169-174. (Pubitemid 34615740)
24. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000; 20: 1323-1329. (Pubitemid 30262934)
25. Park KW, Choi JH, Kim HK, Oh S, Chae IH, Kim HS, Oh BH, Lee MM, Park JB, Choi YS. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet. 2003; 63: 31-38. (Pubitemid 36949892)
26. Tato F, Vega GL, Grundy SM. Determinants of Plasma HDL-cholesterol in hypertriglyceridemic patients: role of cholesterol ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol. 1997; 17: 56-63. (Pubitemid 27057325)
27. Föger B, Ritsch A, Doblinger A, Wessels H, Patsch JR. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1996; 16: 1430-1436. (Pubitemid 26427595)
28. Zheng H, Liu W, Anderson LY, Jiang QX. Lipid-dependent gating of a voltage-gated potassium channel. Nat Commun 2011; 2: 250.
29. Poehlman ET, Toth MJ, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 1997; 27: 322-326 (Pubitemid 27163257)
30. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005; 294: 1773-1781 (Pubitemid 41434623)